Inhaled Antibiotics Market, by Product Type (Aerosol, Dry Powder Formulation, and Spray), by Application (Pneumonia, Asthma, Bronchitis, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (N

Inhaled Antibiotics Market, by Product Type (Aerosol, Dry Powder Formulation, and Spray), by Application (Pneumonia, Asthma, Bronchitis, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Inhaled antibiotics are used to treat chronic airway infection. The earliest experience with inhaled antibiotics involved aerosolizing antibiotics designed for parenteral administration. These formulations caused significant bronchial irritation due to added preservatives and non-physiologic chemical composition. A major therapeutic advance took place when tobramycin designed for inhalation was approved by the U.S. Food and Drug Administration (FDA) for use in patients with cystic fibrosis (CF) with chronic Pseudomonas Aeruginosa infection. Increasing application of inhaled antibiotic in targeted drug delivery is expected to drive the market growth over the forecast period.
Market Dynamics
The major factors driving growth of the inhaled antibiotics market include rising incidence of chronic respiratory disorders, rapid technological advancements, and increasing research and development activities for the development of novel products. Moreover, major players operating in the global market are focusing on adoption of inorganic growth strategies such as partnership and collaboration, in order to expand its product portfolio and strengthen their research and development activities. For instance, in October 2021, Alaxia, a French biotech company, partnered with the European consortium iABC, to accelerate the development of ALX-009, an investigational inhaled antibiotic for multi-drug resistant lung infections in people with cystic fibrosis. Under the partnership, Alaxia will provide support for setting up clinical trials and recruiting patients, and will gain access to expertise on antimicrobial agents from iABC members.
Key features of the study:
This report provides in-depth analysis of the global inhaled antibiotics market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global inhaled antibiotics market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Gilead Sciences, Aradigm, Lupin Ltd., Polyphor, Insmed Incorporated, Pharmaero, Savara Pharmaceuticals, Joincare Pharmaceutical Group, and Pharmaxis Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global inhaled antibiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global inhaled antibiotics market
Detailed Segmentation:
Global Inhaled Antibiotics Market, By Product Type:
Aerosol
Dry Powder Formulation
Spray
Global Inhaled Antibiotics Market, By Application:
Pneumonia
Asthma
Bronchitis
Others
Global Inhaled Antibiotics Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Inhaled Antibiotics Market, By Region:
North America
By Product Type:
Aerosol
Dry Powder Formulation
Spray
By Application:
Pneumonia
Asthma
Bronchitis
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Latin America
By Product Type:
Aerosol
Dry Powder Formulation
Spray
By Application:
Pneumonia
Asthma
Bronchitis
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Aerosol
Dry Powder Formulation
Spray
By Application:
Pneumonia
Asthma
Bronchitis
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Aerosol
Dry Powder Formulation
Spray
By Application:
Pneumonia
Asthma
Bronchitis
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type:
Aerosol
Dry Powder Formulation
Spray
By Application:
Pneumonia
Asthma
Bronchitis
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Aerosol
Dry Powder Formulation
Spray
By Application:
Pneumonia
Asthma
Bronchitis
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Gilead Sciences *
Company Overview
Material Portfolio
Financial Performance
Key Highlights
Market Strategies
Aradigm
Lupin Ltd.
Polyphor
Insmed Incorporated
Pharmaero
Savara Pharmaceuticals
Joincare Pharmaceutical Group
Pharmaxis Ltd
“*” marked represents similar segmentation in other categories in the respective section.